FluoroPharma Medical Management
Management criteria checks 1/4
We currently do not have sufficient information about the CEO.
Key information
Thom Tulip
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 8.6yrs |
| CEO ownership | n/a |
| Management average tenure | no data |
| Board average tenure | 11.7yrs |
Recent management updates
Recent updates
CEO
Thom Tulip (70 yo)
8.6yrs
Tenure
US$320,000
Compensation
Dr. Thomas H. Tulip, also known as Thom, Ph D., was Chief Technical Officer at Radiopharm Theranostics Limited since July 28, 2021 and serves as Chief Business Officer. He has been the President of Fluoro...
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, President & Director | 8.5yrs | US$320.00k | no data | |
| Interim Chairman | 13.3yrs | US$83.48k | no data | |
| Member of Scientific Advisory Board | no data | US$3.48k | no data | |
| Member of the Scientific Advisory Board | 16.8yrs | no data | no data | |
| Chair of Scientific Advisory Board | 10.1yrs | no data | no data | |
| Independent Director | no data | US$534.00 | no data | |
| Member of the Scientific Advisory Board | no data | no data | no data | |
| Member of the Scientific Advisory Board | no data | no data | no data | |
| Member of the Scientific Advisory Board | no data | no data | no data |
11.7yrs
Average Tenure
67yo
Average Age
Experienced Board: FPMI's board of directors are seasoned and experienced ( 11.7 years average tenure).